Product Information

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $4.6569 per EA under NDC 33342028307. Its NADAC has been published 89 times since Mar 5, 2025.

FDA first approved this application on Jan 7, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB

amlodipine,valsartan and hydrochlorothiazide
$4.6569per EA

Strength

5; 12.5; 160 mg/1; mg/1; mg/1

NDC

33342028307

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207299

FDA Approved

1/7/2025

TE Code

AB

On Market Since

1/6/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has been published 89 times since Mar 5, 2025, and over the history we have for it it has declined 31.8%. The table below summarizes its recorded NADAC range and movement.

Current price$4.6569 per EA
All-time high$7.2976 (Jun 11, 2025)
All-time low$4.6569 (Oct 21, 2026)
52-week high$7.0156
52-week low$4.6569
Median price$6.8319
Average price$6.5618
Largest weekly change-9.3% (Jul 22, 2026)
Weeks tracked89
Tracking sinceMar 5, 2025

Price History

1W

0.0%

1M

-4.2%

3M

-15.2%

6M

-31.3%

1Y

-31.8%

3Y

N/A

5Y

N/A

All

-31.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine,valsartan and hydrochlorothiazide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $4.6569 per EA (NDC 33342028307), effective Nov 11, 2026.

How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has declined 31.8%. It has been tracked across 89 weekly CMS publications since Mar 5, 2025.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

Since Mar 5, 2025, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB has ranged from a low of $4.6569 (Oct 21, 2026) to a high of $7.2976 (Jun 11, 2025), with a median of $6.8319 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB?

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB (NDC 33342028307) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.